Viewing StudyNCT00050427



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00050427
Status: COMPLETED
Last Update Posted: 2011-04-28
First Post: 2002-12-09

Brief Title: A Study of ET-743 Trabectedin in Patients With Advanced Breast Cancer
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Skin Diseases
Breast Neoplasms
Neoplasms
Neoplasms by Site
Breast Diseases
Keywords:
Name View
Trabectedin View
Yondelis View
ET743 View
Advanced breast cancer View
Breast View
Cancer View
Antineoplastic Agents Alkylating Agents View
Molecular Mechanisms of Pharmacological Action View